unknown
Stage
1
Investors
About
EarlySight develops a cellular-resolution ophthalmic imaging system (Cellularis) that captures microscopic images of retinal structures and is building AI software to detect and monitor retinal disease biomarkers for earlier diagnosis and treatment monitoring.
Explore Earlysight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.